noom glp 1 reviews consumer reports GLP-1 medications are changing the conversation around weight and Noom Members Regained 3x Less

The FDA has documented dosing-error harms with compounded injectable semaglutide and warns specifically against salt forms (semaglutide sodium, semaglutide acetate) different active ingredients than the base form used in approved drugs

use is more start-and-stop than most people assumed. Glucagon-like peptide-1 (GLP-1) drugs mimic the GLP-1 hormone, which helps control insulin and blood sugar levels, decreases appetite and slows digestion of food

It does not provide dosing advice, dose-change recommendations, missed-dose medical instructions, or injection technique guidance

Because of semaglutide and tirzepatide shortages, which have forced patients to involuntarily stop and restart treatment, reliable data on adherence for GLP-1s is not yet available

If the interaction term was not significant, it was excluded from the model and only the main effects were reported

Severe allergic reactions should be reported to the emergency department